Pancuronium Bromide Injection recall in Canada: labelling error risk
In plain language
This recall involves US-labelled Pancuronium Bromide Injection, USP sold in Canada. It's being recalled because its packaging differs from Canadian standards, which could lead to medication errors. This product is for healthcare professionals only.
What to do
- This information is for healthcare professionals.
- Be aware of the different packaging for this product.
- Confirm the correct product selection to avoid confusion with other injectable solutions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Pancuronium Bromide Injection, USP (US-Labelled) 1 mg/mL Solution for Injection
Why this matters
Medication error risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Medication error risk
What should consumers do?
This information is for healthcare professionals. Be aware of the different packaging for this product. Confirm the correct product selection to avoid confusion with other injectable solutions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Medication error risk
When was this product recalled?
This product was recalled on April 29, 2020.